Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1 (Journal of Neuroscience (November 14, 2007) (12546-12554))
Naoya Yamashita(Tohoku Medical and Pharmaceutical University), Yoshio Goshima(Yokohama University of Pharmacy), Takuya Takahashi(Kansai Electric Power Hospital), Pappachan E. Kolattukudy(University of Central Florida), Kohtaro Takei(Yokohama City University Medical Center), Toshio Ohshima(Waseda University), Asa Morita(Yokohama City University), Yutaka Uchida(The University of Osaka), Jérôme Honnorat(Université Claude Bernard Lyon 1), Masahiko Taniguchi(Sapporo Medical University), Hiroshi Usui(Tokyo Medical Center), Fumio Nakamura(Yokohama City University), Nicole Thomasset(Hôpital Pierre Wertheimer)
Journal of Neuroscience
February 6, 2008
Cited by 1
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
|Proceedings of the National Academy of Sciences|1996|900
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702